Found 10 matching trials
Study of the Effects of the Organism on Monomethyl Fumarate (MMF) After the Administration of LAS41008
PHASE1The purpose of this study is to determine how the organism affects MMF (met...
Location
Almirall Investigational Site #1
Observational Study of Persistence on Bafiertam Treatment in Routine Clinical Practice
N/AThis is an open-label, multicenter, observational study of the adherence of...
Location
Gilbert Neurology
Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMS
PHASE4The DELIVER-MS study seeks to answer the question: Does early treatment wit...
Status
Active Not Recruiting
Location
University of Colorado-Anschutz Medical Campus
A Study of ALKS 8700, a Monomethyl Fumarate (MMF) Molecule, in Healthy Adults
PHASE1This study will evaluate the safety, tolerability, and pharmacokinetics of ...
Location
Alkermes Investigational Site
Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial
NAFDA-approved multiple sclerosis (MS) disease-modifying therapies (DMTs) tar...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Treatments Being Tested
Natalizumab/natalizumab-sztn, Alemtuzumab, Ocrelizumab, Rituximab/rituximab-arrx/rituximab-abbs/rituximab-pvvr, Cladribine, Ofatumumab, Ublituximab-xiiy, Ocrelizumab and hyaluronidase-ocsqGlatiramer acetate, Interferons (intramuscular, subcutaneous, pegylated) Teriflunomide, Fumarates (dimethyl, diroximel, monomethyl) Fingolimod, Siponimod, Ozanimod, Ponesimod Bioequivalence Study of Bafiertam 190 mg and Vumerity® 462 mg Delayed-Release Capsules in Fasting Healthy Subjects
PHASE1A single-dose, randomized, open-label, two-way crossover, two-period, two-s...
Location
BioPharma Services, Inc.
Study to Compare GI Tolerability Following Oral Administration of Bafiertam™ or Tecfidera to Healthy Volunteers
PHASE1The primary objective of the study is to compare in healthy subjects, the G...
Location
BioPharma Services, Inc.
Comparative Bioavailability of BAFIERTAM™ (Monomethyl Fumarate) and Tecfidera® (Dimethyl Fumarate) in Healthy Subjects
PHASE1The primary objective of this study was to assess the bioequivalence of the...
Location
Multiple Locations
Montpellier PROspective Cohort in Relapsing Remitting Multiple Sclerosis Using Imaging and Serologic
NASeveral prospective monocentric cohorts of between 250 and 1000 patients ha...
Location
Neurology Department, Hopital Gui de Chauliac
Observational Study in Patients With Relapsing-Remitting Multiple Sclerosis Switched to Bafiertam® From Dimethyl Fumarate
N/AThis is an open-label, multicenter, observational study evaluating GI sympt...
Location
Multiple Locations